Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
J Immunother Cancer
.
2017 Sep 28;5(1):80.
doi: 10.1186/s40425-017-0280-z.
Authors
Ashish M Kamat
1
,
Joaquim Bellmunt
2
,
Matthew D Galsky
3
,
Badrinath R Konety
4
,
Donald L Lamm
5
,
David Langham
6
,
Cheryl T Lee
7
,
Matthew I Milowsky
8
,
Michael A O'Donnell
9
,
Peter H O'Donnell
10
,
Daniel P Petrylak
11
,
Padmanee Sharma
12
,
Eila C Skinner
13
,
Guru Sonpavde
14
,
John A Taylor 3rd
15
,
Prasanth Abraham
12
,
Jonathan E Rosenberg
16
Affiliations
1
University of Texas MD Anderson Cancer Center, 1515 Pressler Unit 1373, Houston, TX, 77030, USA.
[email protected]
.
2
Dana-Farber Cancer Institute, Brookline, MA, 02446, USA.
3
Tisch Cancer Institute at Mount Sinai Medical Center, New York, NY, 10029, USA.
4
University of Minnesota, Minneapolis, MN, 55455, USA.
5
BCG Oncology, Phoenix, AZ, 85032, USA.
6
Bladder Cancer Advocacy Network, North Carolina Triangle Chapter, Chapel Hill, NC, 27517, USA.
7
The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA.
8
University of North Carolina, Chapel Hill, NC, 27599, USA.
9
University of Iowa, Iowa City, IA, 52242, USA.
10
University of Chicago, Chicago, IL, 60637, USA.
11
Yale Cancer Center, New Haven, CT, 06520, USA.
12
University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
13
Stanford University, Stanford, CA, 94305, USA.
14
University of Alabama, Birmingham, AL, 35294, USA.
15
University of Kansas Cancer Center, Kansas City, KS, 66160, USA.
16
Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
PMID:
28962591
PMCID:
PMC5622592
DOI:
10.1186/s40425-017-0280-z
No abstract available
Publication types
Published Erratum
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States
UL1 TR001863/TR/NCATS NIH HHS/United States